190 related articles for article (PubMed ID: 17979192)
1. Negative modulation of signal transduction via interleukin splice variation.
Denessiouk KA; Denesyuk AI; Johnson MS
Proteins; 2008 May; 71(2):751-70. PubMed ID: 17979192
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor.
Bihl MP; Heinimann K; Rüdiger JJ; Eickelberg O; Perruchoud AP; Tamm M; Roth M
Am J Respir Cell Mol Biol; 2002 Jul; 27(1):48-56. PubMed ID: 12091245
[TBL] [Abstract][Full Text] [Related]
3. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
4. Structure of an extracellular gp130 cytokine receptor signaling complex.
Chow D; He X; Snow AL; Rose-John S; Garcia KC
Science; 2001 Mar; 291(5511):2150-5. PubMed ID: 11251120
[TBL] [Abstract][Full Text] [Related]
5. Theoretical investigation of IL-6 multiprotein receptor assembly.
Menziani MC; Fanelli F; De Benedetti PG
Proteins; 1997 Dec; 29(4):528-44. PubMed ID: 9408949
[TBL] [Abstract][Full Text] [Related]
6. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 trans-signalling in chronic inflammation and cancer.
Scheller J; Ohnesorge N; Rose-John S
Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
[TBL] [Abstract][Full Text] [Related]
8. The soluble IL-6 receptors: serum levels and biological function.
Montero-Julian FA
Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067
[TBL] [Abstract][Full Text] [Related]
9. Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction.
Ehlers M; Grötzinger J; deHon FD; Müllberg J; Brakenhoff JP; Liu J; Wollmer A; Rose-John S
J Immunol; 1994 Aug; 153(4):1744-53. PubMed ID: 7519211
[TBL] [Abstract][Full Text] [Related]
10. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes.
Grötzinger J; Kurapkat G; Wollmer A; Kalai M; Rose-John S
Proteins; 1997 Jan; 27(1):96-109. PubMed ID: 9037715
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
[TBL] [Abstract][Full Text] [Related]
12. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
13. Splice variants: a homology modeling approach.
Furnham N; Ruffle S; Southan C
Proteins; 2004 Feb; 54(3):596-608. PubMed ID: 14748006
[TBL] [Abstract][Full Text] [Related]
14. IL-6 transsignaling: the in vivo consequences.
Jones SA; Richards PJ; Scheller J; Rose-John S
J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
[TBL] [Abstract][Full Text] [Related]
15. A novel and rapid prediction assay for the effectiveness of IL-6 receptor specific antisense oligonucleotides by proliferation inhibition of an interleukin-6 dependent cell line.
Lia Varga V; Falus A; Pallinger E; Novák I; Fülöp KA; Toth S; Rose-John S
Cell Biol Int; 2001; 25(3):253-6. PubMed ID: 11352498
[TBL] [Abstract][Full Text] [Related]
16. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
17. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of mRNA of mouse interleukin-4 and interleukin-6.
Yatsenko OP; Filipenko ML; Khrapov EA; Voronina EN; Kozlov VA; Sennikov SV
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):190-6. PubMed ID: 15588696
[TBL] [Abstract][Full Text] [Related]
19. Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130.
Lehmann U; Sommer U; Smyczek T; Hörtner M; Frisch W; Volkmer-Engert R; Heinrich PC; Schaper F; Haan S
Cell Signal; 2006 Jan; 18(1):40-9. PubMed ID: 15927449
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 trans-signaling in inflammatory bowel disease.
Mitsuyama K; Sata M; Rose-John S
Cytokine Growth Factor Rev; 2006 Dec; 17(6):451-61. PubMed ID: 17045835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
